Effects of homeopathy in reducing weight, body fat mass and percent body fat
اسلاید 1: www.tabaye.ir
اسلاید 2: Effects of homeopathy in reducing weight, body fat mass and percent body fat A randomized, double-blind, placebo controlled clinical trialDr. Linda KimDr. Pam SwanDr. Robert WatersMichael SmithJennifer Orlowski
اسلاید 3: What is homeopathy?Like Cures LikeLaw of MinimumsStimulate body’s own healing processIe. Ipecac
اسلاید 4: Effectiveness of HomeopathyA meta-analysis of placebo controlled clinical trials demonstrated that homeopathic effects are not due to placebo alone, there was a 2.45 times greater effect than placeboMeta-analysis of 107 controlled trials showed 76% of those studies were effective
اسلاید 5: Obesity in AdultsEstimated 97 million adults in US are overweight or obeseOverweight defined as BMI of 25 to 29.9 kg/m² and obesity is a BMI of greater than or equal to 30 kg/m²
اسلاید 6: Risk of ObesityHypertensionDyslipidemiaType 2 Diabetes Coronary heart diseaseStrokeGallbladder diseaseOsteoarthritisSleep apneaRespiratory problemsEndometrial, breast, prostate, or colon cancer
اسلاید 7: What were the questions we asked?Does homeopathy promote more weight loss than placebo?What is the short term efficacy of a homeopathic weight loss product?
اسلاید 8: What did the treatment address?Reducing food cravingsRespond to normal satietyImproving metabolismControlling hypoglycemiaMental/emotional issuesexercise
اسلاید 9: The product we used in the studyWeight Control ™ manufactured by Dolisos America Inc.
اسلاید 10: Homeopathics IncludedAnacardium orientaleAntimonium crudumCalcarea carbonicaGraphitesIodiumNuv Vomica
اسلاید 11: Remedies and their roles in weight loss SxAnacardiumAntimoniumCalceraGraphitesIodiumNuxvomicaCurbing HungerXXXXXXImproving metabolismXXXHypo - glycemiaXXOver - eatingXXmoodXXCravingsugarXCravingFatXX
اسلاید 12: MethodsRecruited people from Phoenix metropolitan areaInitial screening was done by phone using inclusion/exclusion criteriaQualified 35 patient, 30 completed
اسلاید 13: MethodsInclusion:Male/female 21-45 y.oBMI 30-39 kg/m²Confirmed menstrual period prior to enrollmentAble to comply with study requirements: informed consent, 2 office visits, follow up monitoring, avoid other diet programs and perform exercise program
اسلاید 14: MethodsExclusion:Pregnant, lactating, or wanting to become pregnantObesity of endocrine originHistory of bulimia or anorexiaHistory of alcohol or drug addiction
اسلاید 15: Methods 4 week trialTake 1 tablet 4 times per day sublingualExercise 4 times per weekWear pedometer dailyFill out daily questionersWeekly phone monitoringOffice visit 2 times
اسلاید 16: Methods: Office visitPhysical exam:BP, pulse, respiration rate, temperatureWeight, height, body measurements hip and waistMetabolic testing with a Bod Pod {ADD HERE}
اسلاید 17: Outcome ParametersBody weight changesBMI, lean body mass, fat mass, percent body fatBody change measurementsCircumference of waist and hipHip/waist ratioMetabolic testingRespiratory exchange rateQuestionairesVAS of hunger, satiety, thirst, mood [daily]Pedometer logQuality of Life Index SF-36, defecation pattern, satisfaction w/ intervention, compliance [2 times]Hamilton Depression scale [2 times]
اسلاید 18: ResultsOf the 35 people enrolled 30 completed the study, giving a 14% drop out rateScreened 126 patients with 230 inquires
اسلاید 19: Body Measurement changesThese were not significant between the active group and the placebo group. There weight decreases and body measurement changes in active group from baseline to end of treatmentThis suggest a pattern of weight reduction, but not a conclusive difference
اسلاید 20: Exercise ComplianceThere was a significant change (p < .05) noted with exercise compliance between active and placeboPatients in active group recorded more exercise on average than placebo
اسلاید 21: QuestionairesThese were significant (P < .05) The daily questionaire asking about hunger, satiety, thirst, mood and defecation should overall improvement in active group as compared to placeboResults from SF –36 confirmed resultsImprovements may have been attributed to increase incidence of exercise in active group
اسلاید 22: Depressive ScaleNo conclusive change in scale and patient compliance between placebo and active group
اسلاید 23: Adverse EffectsNone were reportedThe only complaint reported by some patient was amount of time required to dissolve pill
اسلاید 24: ConclusionIt was not conclusively shown that this product promoted weight loss, however the time interval may have been to short to draw a significant conclusionIt was conclusively shown that the active group did notice changes in quality of life issues, suggesting that the product may be effective at a longer interval
اسلاید 25: Future StudiesWe should do a 3 month study to determine if weight loss would be significant at a longer time interval.
اسلاید 26: Statistical AnalysisEach body measurements were analyzed using a mean, standard deviation, t test and Wilcoxon’s signed rank test. Confidence intervals of 95% were utilized to detect statistical significance
نقد و بررسی ها
هیچ نظری برای این پاورپوینت نوشته نشده است.